The use of different types of cells in unique ways to treat diseases and disorders is known as cell therapy. Advancements in cell research and the growing acceptance of cell therapies for the treatment of multiple chronic indications are forecasted to augment market growth in the future. Growing demand for regenerative medicine is also estimated to open new avenues of opportunities for cell therapy providers in the long run. The global cell therapy market is segmented into cell types, therapy types, therapeutic areas, end user, and regions.
| Report Coverage | Details |
| Market Revenue in 2023 | $ 6.7 billion |
| Estimated Value by 2031 | $ 190.91 billion |
| Growth Rate | Poised to grow at a CAGR of 52% |
| Forecast Period | 2024–2031 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Cell Type, Therapy Type, Therapeutic Area, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the world |
| Report Highlights | High investments in cell therapy research and development |
| Key Market Opportunities | Increasing incidence of musculoskeletal disorders and high use of cell therapies to treat the same |
| Key Market Drivers | Growing use of cell therapies to treat cancer indications |
Global cell therapy market is segmented by cell type, therapy type, end user, therapeutic area, and region. Based on cell type, the market can be segmented into stem cell (bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, others (placenta, and non-specific cells)), non-stem cell. Based on therapy type, the market can be segmented into autologous and allogeneic. Based on end user, the market is segmented into hospitals & clinics, academic & research institutes, and others. Based on therapeutic area, the market is segmented into oncology, malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Request For Report Sample: https://www.skyquestt.com/sample-request/cell-therapy-market
High Demand for Novel Cancer Treatments to Help Oncology Segment Maintain Prominence
Cases of cancer are increasing rapidly on a global level and subsequently the demand for novel treatments for the same as well. Investments in oncology research are also increasing and reaching new heights. Cell therapies have been showing great promise in treating multiple types of cancers. Cell therapy companies are continually focusing on getting new approvals for their offerings related to different cancer indications thereby helping this segment maintain a high market share.
On the other hand, the demand for cell therapies for the treatment of musculoskeletal disorders is estimated to surge at an impressive pace. Rising cases of musculoskeletal tissue degeneration and the growing demand for repair or replacement of damaged musculoskeletal tissues will also create a new business scope for cell therapy providers.
High Use of CAR-T Therapies Helps Autologous Therapies Account for Dominant Share
Autologous cell therapies are preferred for their lower risk of life-threatening complications as compared to other types of therapies. There are also no specific requirements to match the donor and receivers in an autologous cell therapy. A higher possibility of treatment success and reduced risk of transplant rejection are also key factors that help this segment hold a high market share. CAR-T therapies are being extensively used to treat a wide array of indications and they are classified under the autologous segment.
Request For Report Customization: https://www.skyquestt.com/speak-with-analyst/cell-therapy-market
Stem Cells are Estimated to be Used Extensively for Multiple Cell Therapy Types
Stem cells can be guided or manipulated to perform certain biological functions, which is why they are mostly used in cell therapies. Growing investments in stem cell research, the high availability of stem cells, and the proven efficacy of stem cells in the development of novel cell therapies are all factors that help this segment generate new opportunities for cell therapy providers.
High demand for advanced treatments and therapeutics around the world is forecasted to create opportunities for new as well-established cell therapy providers.
Read Full Report with Table of Contents: https://www.skyquestt.com/report/cell-therapy-market
Cell Therapy Market Top Players’ Company Profiles
- Thermo Fisher Scientific, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Becton, Dickinson, and Company (US)
- Lonza Group (Switzerland)
- Sartorius AG (Germany)
- Nkarta, Inc. (US)
- Aurion Biotech (US)
- S. BIOMEDICS (Europe)
- MEDIPOST (South Korea)
- Anterogen Co., Ltd. (South Korea)
- JW Therapeutics (China)
- JCR Pharmaceuticals Co., Ltd. (Japan)
- Johnson & Johnson Services, Inc (US)
- Bristol-Myers Squibb Company (US)
- Gilead Sciences, Inc. (US)
- Novartis AG (Switzerland)
- Intellia Therapeutics (US)
- Iovance Therapeutics (US)
- CRISPR Therapeutics (Switzerland)